Novartis considers reinsurance model to fund next generation therapies
Novartis has announced it is looking into working with reinsurers as a way to help healthcare providers fund the ultra-high...
Trending:
-
![Population aged 80-89 represents the majority of Alzheimer’s Cases]()
Population aged 80-89 represents the majority of Alzheimer’s Cases
-
![Are pharma supply chains ready for the next major disruption?]()
Are pharma supply chains ready for the next major disruption?
-
![Orchard Therapeutics expands gene therapy manufacturing capacity]()
Orchard Therapeutics expands gene therapy manufacturing capacity
-
![Russia and Rusal complete Ebola vaccinations in Guinea]()
Russia and Rusal complete Ebola vaccinations in Guinea
-
![Mylan announces victory over Sanofi in Lantus patent claims]()
Mylan announces victory over Sanofi in Lantus patent claims
-
![Can blockchain stem the tide of counterfeit drugs in India?]()
Can blockchain stem the tide of counterfeit drugs in India?
Expert commentary & analysis from GlobalData
AIBD 2018: development of a cure for IBD
Phase III data of Darzalex could have immediate impact on clinical practice
DJA: ‘The Walmart of pharmaceutical’
Accurate Machines: Blister packing specialists
Most Read
Company releases
Small-Volume Conversion Kit for symphony 7100 Bathless Dissolution Tester
Distek’s small-volume conversion kit for the symphony 7100 bathless dissolution tester combines the advantages of bathless instruments with small sample...
Alkaline Soak for Tough Biologic Residues
Gerteis to Attend PMEC in Delhi, India
This year's PMEC event has opened in Noida, Delhi, India.
Webinar: Reckoning With Risk
Sanitary Sieves for Medicinal Powders
Sri Krishna Pharmaceuticals is an established manufacturer of pharmaceutical products such as acetaminophen (paracetamol), folic...
Company whitepapers
The Future is Modular for Pharmaceutical Packaging
DividellaInnovative High-Containment Sieving System from Russell Finex
Russell FinexPharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction
Malvern PanalyticalTrehalose: A Powerful Excipient in the Formulation Toolbox
PfanstiehlMonomaterial Packaging Benefits
DividellaWhy Did My Plant Close?
NSF International, Pharma BiotechAqueous Cleaning in Pharmaceutical Manufacturing
AlconoxCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Lonza Biologics Facility, Guangzhou, China
Lonza and GE Healthcare are developing a new biologics facility in Guangzhou, China.
GE Healthcare Biotechnology Manufacturing Centre, Stevenage, UK
Knight Cancer Institute Research Building, Oregon
Seqirus Vaccine Manufacturing Facility Expansion, Holly Springs, US
Abzena’s Biotherapeutics Manufacturing Facility Relocation, San Diego
Clinical Trials
Janssen’s Tremfya shows superiority in plaque psoriasis to Novartis’ drug at 48 weeks
Johnson & Johnson subsidiary Janssen has announced results from its phase III Eclipse trial comparing its Tremfya (guselkumab) with Novartis’ Cosentyx (secukinumab) in adults with...
Bristol-Myers and Vedanta to study combination therapy for cancer
AbbVie halts phase III TAHOE trial of Rova-T for SCLC
FDA grants ODD for AstraZeneca’s Fasenra to treat EGPA
Aimmune publishes phase III data for peanut allergy drug
Drug Development
AbbVie licences BioArctic’s Parkinson’s disease portfolio
Swedish biopharma company BioArctic has secured clearance from US Federal Trade Commission (FTC) to out-licence its alpha-synuclein antibody portfolio to AbbVie.
Nicox and Ocumension partner to develop and commercialise glaucoma drug
Lilly teams up with AC Immune for Alzheimer’s drug
NIH to support HIV care and prevention research in the US
GARDP, Eisai and Takeda join forces to identify new antibiotics
Market Data
Russia and Rusal complete Ebola vaccinations in Guinea
The Ministry of Health of the Russian Federation and domestic aluminium producer Rusal have completed the vaccination against Ebola virus in the Republic of Guinea.
Deals this week: Vect-Horus, Amgen, Bristol-Myers Squibb
Mylan announces victory over Sanofi in Lantus patent claims
M&As this week: GlaxoSmithKline, Takeda, Procter & Gamble
Deals this week: Boehringer Ingelheim, UCB, Janssen Pharmaceutical
Technology
Merck partners with Cyclica for AI-based screening of drug targets
Merck has signed an agreement to licence Canada-based Cyclica’s cloud-based in-silico proteome screening platform called Ligand Express to support its research efforts.
Fluidic Analytics gains funding for lab-tools products launch
Lupin launches chatbot ANYA for health-related queries
Elsevier introduces cloud-based platform for life sciences companies
Otsuka expands digital medicines alliance with Proteus Digital
Go Top